Moody National Bank Trust Division Purchases 23,003 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)

Moody National Bank Trust Division raised its position in AngioDynamics, Inc. (NASDAQ:ANGO) by 70.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 55,780 shares of the medical instruments supplier’s stock after buying an additional 23,003 shares during the quarter. Moody National Bank Trust Division’s holdings in AngioDynamics were worth $511,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Systematic Financial Management LP raised its stake in AngioDynamics by 14.3% in the 3rd quarter. Systematic Financial Management LP now owns 2,410,346 shares of the medical instruments supplier’s stock valued at $18,752,000 after acquiring an additional 300,785 shares during the period. Millennium Management LLC raised its position in shares of AngioDynamics by 41.9% in the second quarter. Millennium Management LLC now owns 1,793,454 shares of the medical instruments supplier’s stock valued at $10,850,000 after purchasing an additional 529,861 shares during the period. Royce & Associates LP lifted its stake in shares of AngioDynamics by 10.8% during the 3rd quarter. Royce & Associates LP now owns 986,073 shares of the medical instruments supplier’s stock valued at $7,672,000 after buying an additional 96,138 shares in the last quarter. Geode Capital Management LLC boosted its holdings in AngioDynamics by 5.1% in the 3rd quarter. Geode Capital Management LLC now owns 960,767 shares of the medical instruments supplier’s stock worth $7,477,000 after buying an additional 46,409 shares during the period. Finally, Segall Bryant & Hamill LLC grew its stake in AngioDynamics by 142.7% in the 3rd quarter. Segall Bryant & Hamill LLC now owns 911,443 shares of the medical instruments supplier’s stock valued at $7,091,000 after buying an additional 535,958 shares in the last quarter. Hedge funds and other institutional investors own 89.43% of the company’s stock.

AngioDynamics Price Performance

NASDAQ ANGO opened at $11.80 on Wednesday. The company’s 50 day simple moving average is $8.44 and its two-hundred day simple moving average is $7.53. AngioDynamics, Inc. has a 1 year low of $5.26 and a 1 year high of $13.13. The stock has a market capitalization of $479.48 million, a PE ratio of -1.94 and a beta of 0.59.

AngioDynamics (NASDAQ:ANGO) last issued its quarterly earnings data on Wednesday, January 8th. The medical instruments supplier reported ($0.04) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.07. AngioDynamics had a negative return on equity of 5.86% and a negative net margin of 83.95%. The company had revenue of $72.90 million for the quarter, compared to the consensus estimate of $70.93 million. During the same quarter last year, the business posted ($0.05) earnings per share. The firm’s revenue was down .1% compared to the same quarter last year. On average, research analysts anticipate that AngioDynamics, Inc. will post -0.41 EPS for the current year.

Wall Street Analysts Forecast Growth

ANGO has been the topic of several recent research reports. HC Wainwright increased their target price on AngioDynamics from $14.00 to $15.00 and gave the stock a “buy” rating in a research report on Friday, January 10th. Canaccord Genuity Group dropped their price objective on AngioDynamics from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, October 4th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.